All Stories

  1. Synthesis, antifungal evaluation and in silico study of novel Schiff bases derived from 4-amino-5(3,5-dimethoxy-phenyl)-4H-1,2,4-triazol-3-thiol
  2. A new simple and rapid validated RP-HPLC method for determination of ziprasidone in ziprasidone capsules
  3. Fused Aryl-Phenazines: Scaffold for the Development of Bioactive Molecules
  4. Binding mode prediction and identification of new lead compounds from natural products as renin and angiotensin converting enzyme inhibitors
  5. Analysis of surface area features of structurally diverse molecules for Bcr/Abl kinase inhibitory activity and antiproliferative activity
  6. Development of Ribonucleotide Reductase Inhibitors: A Review on Structure Activity Relationships
  7. Synthesis and evaluation of some amino acid conjugates of pirprofen
  8. Synthesis and evaluation of some amino acid conjugates of suprofen
  9. 6H-Indolo[2,3-b]Quinoxalines: DNA and Protein Interacting Scaffold for Pharmacological Activities
  10. Atom based 3D-QSAR study of 1,4-benzodiazepine-2-ones as potent anti-trypanosomal agents and its validation
  11. Aryl- and Heteroaryl-Thiosemicarbazone Derivatives and Their Metal Complexes: A Pharmacological Template
  12. Predictive QSAR models development and validation for human ether-a-go-go related gene (hERG) blockers using newer tools
  13. QSAR and Pharmacophore Analysis of a Series of Piperidinyl Urea Derivatives as hERG Blockers and H3 Antagonists
  14. Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B
  15. Aryl- and Heteroaryl-Thiosemicarbazone Derivatives and Their Metal Complexes: A Pharmacological Template
  16. QSAR and Pharmacophore Analysis of a Series of Piperidinyl Urea Derivatives as hERG Blockers and H3 Antagonists
  17. Combined ligand and structure based binding mode analysis of oxidosqualene cyclase inhibitors
  18. Human Ether-a-Go-Go-Related Gene Channel Blockers and its Structural Analysis for Drug Design
  19. Human Ether-a-Go-Go-Related Gene Channel Blockers and its Structural Analysis for Drug Design
  20. In silico Based Structural Analysis of Some Piperidine Analogs as Farnesyltransferase Inhibitors
  21. Synthesis, Characterization, Biological Evaluation and Docking of Coumarin Coupled Thiazolidinedione Derivatives and its Bioisosteres as PPARγ Agonists
  22. Structural Analysis of 2-Piperidin-4-yl-Actamide Derivatives for hERG Blocking and MCH R1 Antagonistic Activities
  23. Modeling VEGFR kinase inhibition of aminopyrazolopyridine urea derivatives using topological and physicochemical descriptors: a quantitative structure activity analysis study
  24. Structural analysis of α-glucosidase inhibitors by validated QSAR models using topological and hydrophobicity based descriptors
  25. Analysis of the α-Glucosidase Inhibitory Activity of Chromenone Derivatives Based on their Molecular Features: A Computational Study
  26. Comparative Structural Analysis of α‐Glucosidase Inhibitors on Difference Species: A Computational Study
  27. COMPARATIVE STUDY OF FORCED DEGRADATION BEHAVIOR OF PRASUGREL BY UPLC AND HPLC AND THE DEVELOPMENT OF VALIDATED STABILITY INDICATING ASSAY METHOD
  28. In Silico–Based Structural Analysis of Arylthiophene Derivatives for FTase Inhibitory Activity, hERG, and Other Toxic Effects
  29. Structural analysis of structurally diverse α-glucosidase inhibitors for active site feature analysis
  30. A Validated UPLC Method Used for the Determination of Trandolapril and its Degradation Products as per ICH Guidelines
  31. Design, synthesis and biological evaluation of some novel 3-cinnamoyl-4-hydroxy-2H-chromen-2-ones as antimalarial agents
  32. Synthesis, in silico metabolic and toxicity prediction of some novel imidazolinones derivatives as potent anticonvulsant agents
  33. Synthesis of Some Coumarinyl Chalcones and their Antiproliferative Activity Against Breast Cancer Cell Lines
  34. Structural feature study of benzofuran derivatives as farnesyltransferase inhibitors
  35. QSAR and pharmacophore analysis of thiosemicarbazone derivatives as ribonucleotide reductase inhibitors
  36. Topological, hydrophobicity, and other descriptors on α-glucosidase inhibition: a QSAR study on xanthone derivatives
  37. hERG binding feature analysis of structurally diverse compounds by QSAR and fragmental analysis
  38. QSAR Analysis of Isosteviol Derivatives as α-Glucosidase Inhibitors with Element Count and Other Descriptors
  39. Prediction of the relationship between the structural features of andrographolide derivatives and α-glucosidase inhibitory activity: A quantitative structure-activity relationship (QSAR) Study
  40. QSAR analysis of 2-benzoxazolyl hydrazone derivatives for anticancer activity and its possible target prediction
  41. 3D QSAR of Aminophenyl Benzamide Derivatives as Histone Deacetylase Inhibitors
  42. A new approach for PEGylation of dendrimers
  43. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives
  44. Synthesis, Cytotoxic Evaluation and In Silico Pharmacokinetic Prediction of Some Benzo[a]Phenazine-5-sulfonic acid Derivatives
  45. QSAR study on N- (Aryl)-4-(Azolylethyl) Thiazole-5-Carboxamides: Novel Potent Inhibitors of VEGF Receptors I and II
  46. QSAR study of substituted 2-pyridinyl guanidines as selective urokinase-type plasminogen activator (uPA) inhibitors
  47. Quantitative Structure Activity Analysis of 2-Alkoxydihydrocinnamates as PPARα /γ Dual Agonist
  48. Synthesis and Anti-microbial Evaluation of Some 3, 4-Dihydro Pyrimidine-2-one Derivatives
  49. Quantitative Structure Activity Relationship Analysis of Some Diarylsulphonylurea Derivatives as Tubulin Binding Agents
  50. Synthesis, Biological Evaluation and in silico Metabolic and Toxicity Prediction of Some Flavanone Derivatives.
  51. QSAR Studies of 6‐Amino Uracil Base Analogues: A Thymidine Phosphorylase Inhibitor in Cancer Therapy
  52. Synthesis and Physicochemical Characterization of Mutual Prodrug of Indomethacin
  53. Synthesis and Characterization of Some Chalcone Derivatives
  54. Insulin like Growth Factor-1 Receptor: An Anticancer Target Waiting for Hit
  55. Comparative Studies on Conventional and Microwave Assisted Synthesis of Benzimidazole and Their 2-Substituted Derivative with the Effect of Salt Form of Reactant
  56. QSAR Analysis of HIV-1 Reverse Transcriptase Inhibitory 5-Alkyl-2- [(Aryl and Alkyloxylcarbonylmethyl) Thio]-6- (1-Napthylmethyl) Pyrimidin-4 (3H)-Ones
  57. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase
  58. 2-(4-Aminophenyl) Benzothiazole: A Potent and Selective Pharmacophore with Novel Mechanistic Action Towards Various Tumour Cell Lines
  59. Quantitative Structure Activity Relationships of Some Selective Inhibitors of Glucagon Receptor: A Hansch Approach
  60. QSAR Studies on Some GSK-3a Inhibitory 6-aryl-pyrazolo (3,4-b) pyridines
  61. Synthesis, Biological Evaluation and In Silico Metabolic and Toxicity Prediction of Some Flavanone Derivatives
  62. Quantitative Structure–Activity Relationships of Selective Antagonists of Glucagon Receptor Using QuaSAR Descriptors
  63. Dihydrofolate Reductase Enzyme: A Potent Target for Antimalarial Research
  64. QSAR modelling of HIV-1 reverse transcriptase inhibition by benzoxazinones using a combination of P_VSA and pharmacophore feature descriptors